Home > Keywords >
Catalog | name | Description | price |
---|---|---|---|
R-R-3642 | PLLA electrospun membrane doped with ferric oxide | PLLA electrospun membrane doped with ferric oxide/Poly-L-lactic acid electrospun membrane doped with ferric oxide from ruixi. A PLLA (poly-L-lactic acid) electrospun membrane doped with ferric oxide is a composite material that combines the properties of PLLA with the unique characteristics of ferric oxide. Combining PLLA with ferric oxide through the electrospinning process results in a membrane with enhanced properties such as biocompatibility, mechanical strength, and magnetic responsiveness. This composite material holds promise for applications in tissue engineering, controlled drug delivery, and biomedical imaging. | price> |
R-C-1943 | PU-WS13 CAS:1454619-14-7 | PU-WS13 is a potent,Grp94-specific Hsp90 inhibitor of the purine scaffold class. PU-WS13 is a cell-permeable inhibitor of Grp94 with EC50 of 220 nM. | price> |
R-R-3643 | PLA electrospun fiber film | Polylactic acid electrospun fiber film/PLA electrospun fiber film is a nanofiber film made of polylactic acid (PLA) prepared by electrospinning technology. PLA is a biocompatible and degradable polymer material that is non-toxic and has good mechanical properties. Therefore, PLA electrospun fiber films have broad application prospects in the biomedical field. PLA electrospun fiber membrane has high specific surface area, high porosity and good cell compatibility. Its fiber structure simulates the structure of the natural extracellular matrix, providing a suitable growth environment for cells. This fiber film can promote cell adhesion and proliferation, thereby promoting tissue regeneration and repair. Therefore, PLA electrospun fiber films have wide applications in tissue engineering, cell culture, drug delivery, wound dressing and other fields. As a tissue engineering scaffold material, PLA electrospun fiber films can provide three-dimensional growth space for cells, support cell growth and differentiation, and promote tissue regeneration. As a drug delivery carrier, this fiber film can load drugs and control the release rate of drugs, achieve targeted delivery and sustained release of drugs, and improve the therapeutic effect of drugs. In addition, due to its good biocompatibility and mechanical properties, PLA electrospun fiber films can also be used in wound dressings to provide protection and support for wounds and promote wound healing. | price> |
R-C-1944 | PF-06454589 CAS:1527473-30-8 | PF-06454589 is a potent and selective LRRK2 inhibitor. | price> |
R-R-3644 | PLLA nanofiber membrane | PLLA nanofiber membrane/Poly-L-lactic acid nanofiber membrane from ruixi. PLLA nanofiber membrane is a nanoscale fiber membrane material made of polylactic acid (PLLA). Polylactic acid is a biodegradable and biocompatible polymer material, so it has a wide range of applications in the biomedical field. Through electrospinning technology, PLLA can be processed into nanoscale fibers to form fiber membranes with high specific surface area and high porosity.PLLA nanofiber membrane has many properties, such as good mechanical properties, biocompatibility, biodegradability and cell compatibility. Its nanoscale fiber structure can simulate the structure of the natural extracellular matrix and provide a suitable growth environment for cells. Therefore, PLLA nanofiber membranes have broad application prospects in tissue engineering, cell culture, drug delivery, wound dressing and other fields. In terms of tissue engineering, PLLA nanofiber membranes can be used as scaffold materials to provide three-dimensional growth space for cells, promote cell growth and differentiation, and then promote tissue regeneration. In terms of drug delivery, PLLA nanofiber membranes can load drugs and control drugs. The release rate achieves targeted delivery and sustained release of drugs and improves the therapeutic effect of drugs. | price> |
R-C-1945 | PHCCC CAS:179068-02-1 | PHCCC is a Group I mGluR antagonist with an IC50 of 3 μM.PHCCC is a selective positive modulator of mGlu4 receptor.Antiparkinsonian effect. | price> |
R-R-3645 | Cellulose acetate nanofiber membrane | Cellulose acetate nanofiber membrane/CA nanofiber membrane is a nanofiber membrane material prepared by electrospinning technology, which has high specific surface area, high porosity, and good mechanical properties. This fiber membrane material is mainly made of cellulose acetate (CA) and processed through specific spinning processes. Cellulose acetate is a cellulose derivative with good biocompatibility and biodegradability, and is therefore widely used in the biomedical field. Through electrospinning technology, cellulose acetate can be processed into nanoscale fibers to form fiber membranes with high porosity and specific surface area. This fibrous membrane structure is conducive to cell adhesion and proliferation, and can promote tissue regeneration and repair,Cellulose acetate nanofiber membrane has a wide range of applications in the fields of tissue engineering, drug delivery, wound dressings, and biosensors. As a scaffold material for tissue engineering, it can provide three-dimensional growth space for cells, support cell growth and differentiation, promote tissue regeneration. As a drug delivery carrier, cellulose acetate nanofiber membrane can load drugs and control drug release rate, achieve targeted delivery and sustained release of drugs, and improve the therapeutic effect of drugs. In addition, due to its good biocompatibility and mechanical properties, cellulose acetate nanofiber membrane can also be used for wound dressings, providing protection and support for wounds, and promoting wound healing. | price> |
R-C-1946 | QNZ46 CAS:1237744-13-6 | QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist(IC50 values are 3,6,229,and>300,>300μM for NR2D,NR2C,NR2A,NR2B,and GluR1, respectively). | price> |
R-R-3646 | 1% Rhodamine doped SF (5% -10%) - PLGA electrospun fiber | 1% Rhodamine doped SF (5% -10%) - PLGA electrospun fiber membrane/1% Rhodamine doped silk fibroin (5% -10%) - polylactic acid-polycaprolactone electrospun fiber membrane from ruixi. 1% rhodamine doped SF (5%-10%)-PLGA electrospun fiber membrane is a composite nanofiber membrane that combines the properties of multiple materials. This fiber membrane is made of polylactic acid-polycaprolactone (PLGA) As the basic material, 5% to 10% silk fibroin (SF) and 1% rhodamine dye are also incorporated. Through electrospinning technology, these materials are processed into nanoscale fibers to form unique properties. Electrospun fiber membrane. 1% rhodamine-doped SF (5%-10%)-PLGA electrospun fiber membrane combines the advantages of PLGA, SF and rhodamine, and has high specific surface area, high porosity, good mechanical properties, and biocompatibility and fluorescence properties. This kind of fiber membrane has potential application value in tissue engineering scaffold materials, drug delivery carriers and cell tracers. However, its performance and application may be affected by factors such as material preparation conditions, fiber morphology and composition, so it is necessary to Conduct further research and optimization. | price> |
R-C-1947 | IMR-1 CAS:310456-65-6 | IMR-1 is a novel class of Notch inhibitors targeting the transcriptional activation with an IC50 of 26μM.IMR-1 prevents the recruitment of Mastermind-like 1(Maml1)to the Notch Ternary Complex(NTC)on chromatin,inhibits Notch target gene transcription and dramatically inhibits tumor growth. | price> |
R-R-3647 | PCL silk fibroin 1% - gelatin 1% | PCL silk fibroin 1% - gelatin 1%/PCL SF 1% - gelatin 1%/Polycaprolactone silk fibroin 1% - gelatin 1%/Polycaprolactone SF 1% - gelatin 1% from ruixi. A blend of PCL (polycaprolactone), silk fibroin (SF), and gelatin at 1% concentration can be used to create a composite material with unique properties.A blend of PCL, silk fibroin, and gelatin at 1% concentration offers a versatile platform for creating composite materials with a blend of mechanical, biodegradable, and biological properties, making it suitable for a variety of biomedical and pharmaceutical applications. | price> |
R-C-1948 | CCF-642 CAS:346640-08-2 | CCF642 is a potent protein disulfide isomerases(PDI)inhibitor with an IC50 of 2.9μM.CCF642 causes acute endoplasmic reticulum(ER)stress in multiple myeloma cells accompanied by apoptosis-inducing calcium release.CCF642 has broad anti-multiple myeloma activity. | price> |
R-R-3648 | Sc-polylactic acid-PLGA-CTS-electrospun nanofiber scaffold | Sc-polylactic acid-PLGA-CTS-electrospun nanofiber scaffold/Schwann cell polylactic acid hydroxyacetic acid chitosan electrospun nanofiber scaffold from ruixi.Schwann cells polylactic acid hydroxyacetic acid chitosan electrospun nanofiber scaffolds are usually prepared through electrospinning and other techniques. During the electrospinning process, the polymer solution is sprayed into fibers, which are then stretched to a nanoscale size under the action of an electric field, forming a nanofiber scaffold. During the preparation process, the morphology, size, and structure of fibers can be controlled by adjusting parameters such as solution composition and spinning conditions. | price> |
R-C-1949 | Riociguat(BAY 63-2521) CAS : 625115-55-1 | Riociguat is an oral stimulator of soluble guanylate cyclase(sGC)used in the treatment of pulmonary hypertension. | price> |
R-R-3649 | Sc-polycaprolactone-CTS electrospun nanofiber scaffold | Schwann cell-polycaprolactone-chitosan electrospun nanofiber scaffold/Sc-polycaprolactone-CTS electrospun nanofiber scaffold from ruixi. Schwann cells polycaprolactone chitosan electrospun nanofiber scaffolds are usually prepared through electrospinning and other techniques. During the electrospinning process, the polymer solution is sprayed into fibers, which are then stretched into nanoscale sizes under the action of an electric field, forming a nanofiber scaffold. During the preparation process, the morphology, size, and structure of the fibers can be controlled by adjusting the solution composition, spinning conditions, and other parameters. | price> |
R-C-1950 | STK321130 CAS:923562-23-6 | STK321130(FLT3-IN-2)is potent FLT3 inhibitor. | price> |
R-R-3650 | Human periodontal ligament fibroblasts grafted with polycaprolactone nanoelectrospun fiber scaffold | Human periodontal ligament fibroblasts are connected to a nanoelectrospun fiber scaffold of caprolactone, which is usually prepared through techniques such as electrospinning. During the electrospinning process, polymer solutions are sprayed into fibers and stretched into nano-sized structures under the action of an electric field, forming nanofiber scaffolds. During the preparation process, the morphology, size, and structure of fibers can be controlled by adjusting parameters such as solution composition and spinning conditions. | price> |
R-C-1951 | 4μ8C CAS:14003-96-4 | 4μ8C(IRE1 Inhibitor III)is a IRE1 Inhibitor.4µ8C inhibits IRE1α splicing of Xbp1 mRNA(IC50=6.8µM)and reduces subsequent gene expression of Erdj4 (IC50=3.4µM)in stress-cultured MEF cells but does not block IRE1α autophosphorylation. | price> |
R-R-3651 | Human periodontal ligament fibroblasts grafted with PLA nanoelectrospun fiber scaffold | Human periodontal ligament fibroblasts grafted with polylactic acid nanoelectrospun fiber scaffold/Human periodontal ligament fibroblasts grafted with PLA nanoelectrospun fiber scaffold from ruixi.Human periodontal ligament fibroblasts are connected to polylactic acid nano-electrospinning fiber scaffolds. Nano-fiber scaffolds are usually prepared through technologies such as electrospinning. During the electrospinning process, the polymer solution is sprayed into fibers. And under the action of electric field, it is stretched to nanoscale size to form a nanofiber scaffold. During the preparation process, the shape, size and structure of the fiber can be controlled by adjusting parameters such as solution composition and spinning conditions. | price> |
R-C-1952 | FX1 CAS:1426138-42-2 | FX1 is a selective BCL6 BTB inhibitor with an IC50 value of 35μM in reporter assays.FX1 shows great selectivity against a panel of 50 different kinases.10 μM FX1 fails to significantly inhibit of any of these kinases.FX1 induces apoptosis. | price> |